Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  203.91
-6.20 (-2.95%)
AAPL  268.93
+4.35 (1.64%)
AMD  195.09
-5.06 (-2.53%)
BAC  51.31
-1.75 (-3.30%)
GOOG  313.56
-1.33 (-0.42%)
META  642.19
-13.47 (-2.05%)
MSFT  386.85
-10.38 (-2.61%)
NVDA  191.49
+1.67 (0.88%)
ORCL  140.04
-8.04 (-5.43%)
TSLA  396.11
-15.71 (-3.81%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.